维普中文期刊产品整合服务
36篇 您的检索式:作者名="Joshua U"
    题名 作者 年代 出处 被引量
1Analytic thermogravimetry to determine the effect of surface modification on dispersion of NdFeB fillers 显示文摘 Joshua U O 1999J Mater Res1999,14,7:1
2Modeling of magnetic properties of polymer bonded Nd-Fe-B magnets with surface modifications 显示文摘 Joshua U O David C J 2000Journal of Magnetism and Magnetic Materials2000,218,:1
3Rheokinetics of thermal-induced gelation of waterborne polyurethane dispersions显示文摘SAMY A MADBOULY JOSHUA U OTAIGBE 2005Macromolecules2005,38,10:1
4P, heoki- netics of themlal -induced gelation of waterbrne polyurethane dispersions 显示文摘SAMYA MADBOULY JOSHUA U OTAIGBE 2005Macromolecules2005,38,10:1
5Bio-absorbable soy protein plastic composites:Effect of polyphosphate fillers on biodegradability显示文摘ALAN H T JOSHUA U O KAI-LAI G H 2001Journal of Polymers and the Environment2001,,1:1
6Recent advances in synthesis,characterization and rheological properties of polyurethanes and POSS/polyurethane nanocomposites dispersions and films显示文摘Samy A Madbouly Joshua U Otaigbe 2009Progress Polym Sci2009,34,12:1
7Recent advances in synthesis, characterization and rheological properties of pol yurethanes and POSS/polyurethane nanocomposites disper- sions and films显示文摘Samy A Madbouly Joshua U Otaigbe 2009Prog Polym Sci2009,34,12:1
8Protein identification using sequential ion/ion reactions and tandem mass spectrometry显示文摘JOSHUA J C BEATRIX U JOHN E P S 2005Proc Natl cad Sci USA72005,102,27:1
9Rheokinetics of thermal - induced gelation of waterborne polyurethane dispersions 显示文摘SAMY A MADBOULY JOSHUA U OTA1GBE 2005Macromoleeules2005,38,10:1
10Kinetic analysis of fractal gel formation in waterborne polyurethane dispersions undergoing high deformation flows显示文摘Samy A Madbouly Joshua U Otaigbe 2006Macromolecules2006,39,:1
11Kinetic analysis of fractal gel formation in waterborne polyurethane dispersions undergoing high deformation floes显示文摘SAMY A MADBOULY JOSHUA U OTAIGBE 2006Macromolecules2006,39,12:1
12Kinetic analysis of fractal gel formation in waterborne polyurethane dispersions undergoing high deformation flows显示文摘SAMY A M JOSHUA U O 2006Macromolecules2006,39,:1
13Rheokineties of thermal-induced gelation of waterborne polyurethane dispersions 显示文摘SAMY A M JOSHUA U O 2005Maeromolecules2005,38,10:1
14Towards modeling of assemblies for product design显示文摘Rajneet Sodhi Joshua U Turner 1994Computer-Aided Design1994,26,2:1
15Review of statistical approaches to tolerance analysis 显示文摘Nigam Swami D Uurner Joshua U 1995Computer-Aided Design1995,27,1:1
16Cytochrome 17450/ NADPH-dependent biosynthesis of 5,6-trans-epoxyeicosatrienoic acid from 5,6-trans-arachidonic acid 显示文摘Roy U Joshua R Stark R L 2005Biochem J2005,390,3:1
17Compatibilized Polyimide(R-BAPS)/BAPS-modified Clay Nanocomposites with lmproved Dispersion and Properties显示文摘Takashi Kurose Vladimir E Yudin Joshua U Otaigbe 2007Polymer2007,48,24:1
18Real-world cure rates for hepatitis C virus treatments that include simeprevir and/or sofosbuvir are comparable to clinical trial results显示文摘AIM To assess the real-world effectiveness and cost of simeprevir(SMV), and/or sofosbuvir(SOF)-based therapy for chronic hepatitis C virus(HCV) infection.METHODS The real-world performance of patients treated with SMV/SOF ± ribavirin(RBV), SOF/RBV, and SOF/RBV with pegylated-interferon(PEG) were analyzed in a consecutive series of 508 patients with chronic HCV infection treated at a single academic medical center. Patients with genotypes 1 through 4 were included. Rates of sustained virological response-the absence of a detectable serum HCV RNA 12 wk after the end of treatment [sustained virological response(SVR) 12]-were calculated on an intention-to-treat basis. Costs were calculated from the payer's perspective using Medicare/Medicaid fees and Redbook Wholesale Acquisition Costs. Patient-related factors associated with SVR12 were identified using multivariable logistic regression.RESULTS SVR 12 rates were as follows: 86%(95%CI: 80%-91%)among 178 patients on SMV/SOF ± RBV; 62%(95%CI: 55%-68%) among 234 patients on SOF/RBV; and 78%(95%CI: 68%-86%) among 96 patients on SOF/PEG/RBV. Mean costs-per-SVR 12 were $174442(standard deviation: ± $18588) for SMV/SOF ± RBV; $223003(± $77946) for SOF/RBV; and $126496(± $31052) for SOF/PEG/RBV. Among patients on SMV/SOF ± RBV, SVR12 was less likely in patients previously treated with a protease inhibitor [odds ratio(OR): 0.20, 95%CI: 0.06-0.56]. Higher bilirubin(OR: 0.47, 95%CI: 0.30-0.69) reduced the likelihood of SVR12 among patients on SOF/RBV, while FIB-4 score ≥ 3.25 reduced the likelihood of SVR 12(OR: 0.18, 95%CI: 0.05-0.59) among those on SOF/PEG/RBV. CONCLUSION SVR 12 rates for SMV and/or SOF-based regimens in a diverse real-world population are comparable to those in clinical trials. Treatment failure accounts for 27% of costs.Kian Bichoupan Neeta Tandon James F Crismale Joshua Hartman David Del Bello Neal Patel Sweta Chekuri Alyson Harty Michel Ng Keith M Sigel Meena B Bansal Priya Grewal Charissa Y Chang Jennifer Leong Gene Y Im Lawrence U Liu Joseph A Odin Nancy Bach Scott L Friedman Thomas D Schiano Ponni V Perumalswami Douglas T Dieterich Andrea D Branch 2017World Journal of Virology2017,6,4:1
19New phosphate glass/polymer hybrids-current status and future prospects显示文摘Kevin Urman Joshua U Otaigbe 2007Prog Polym Sci2007,32,:1
20Recent advances insynthesis, characterization and rheological properties of polyurethanes and POSS/polyurethane nanocomposites dispersions and films显示文摘Samy A Madbouly Joshua U Otaigbe 2009Prog Ploym Sci2009,34,:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费